Antibody Drug Conjugate Drug Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1062396
  • May 2021
  • Pharmaceuticals
  • 118 Pages
The global Antibody Drug Conjugate Drug market research report provides complete study and detail analysis of the market. This study includes forecast analysis of the market which is based on global and regional level, whereas the research reports the provides forecast data from 2020-2028 and historic of 2018 and 2019. All the values are based on revenue USD Million. Moreover, the market research report describes various segments of the Antibody Drug Conjugate Drug market based on its types, applications and end-use industry. The applications of the market are explained in different industry verticals with reference to major countries across the globe. Along with this, the research report also covers all the major players that are operating in the global Antibody Drug Conjugate Drug market. These major players of the market are further studied and analyzed based on various parameters, such as annual market revenue, annual sales of the company, marketing strategy, historic growth and shipment volumes. Based on all the company’s insights, the market research analyst also suggests business strategy and marketing plans for improving the market position of existing participants of Antibody Drug Conjugate Drug market.
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Genentech USA, Inc, Seattle Genetics, F. Hoffmann-La Roche Ltd, Takeda Pharmaceuticals, Pfizer Inc, AbbVie Inc, Immunomedics, ImmunoGen Inc, Lonza, Creative Biolabs
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Impact Analysis
The analysis of covid-19 is based on the impact of the current pandemic situation on market scenarios. This includes impact of covid-19 outbreak on overall revenue, market segments as well as regional market. The report also puts light on detailed impact analysis by taking into consideration all the government policies imposed during the pandemic situation, temporary shutdown of manufacturing units, current state of supply chain and distributors, and its future impacts on the growth of overall market. The market study will assist user to understand the global demand and impose strategic business plans to compete with the peers.

Apart from this, the market research report also covers drivers and restraints for the global Antibody Drug Conjugate Drug market and their impact on the demand and supply during the forecast period. Along with this, the research report also provides Antibody Drug Conjugate Drug market trends and opportunities that are based on regional and global level. Furthermore, the market research report also provides the major distributors and manufacturers that are operating in all the key region across the world. The researched data provided in the report is widely used by various industry players to strengthen their distribution channel and improve the geographical reach. In addition, the report also covers all the major players of the global Antibody Drug Conjugate Drug market and its key offerings and solutions. The report also provides recent mergers and acquisitions of these key players.

The data which is provided in the market research report is analyzed and evaluated with the help of various marketing tools, such as SWOT analysis, Poster’s Five Force analysis, PESTEL analysis, value chain analysis, player positioning analysis and market share analysis. Therefore, this analysis tools helps the analyst to evaluate the Antibody Drug Conjugate Drug market based on various parameters such as capital investments, impact of consumer’s preferences, economies of scale, manufacturing rights and patents, existing distribution channels, switching costs, government regulations and brand loyalty.

Major Key Players for Global Antibody Drug Conjugate Drug Market:
The Antibody Drug Conjugate Drug market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Genentech USA, Inc, Seattle Genetics, F. Hoffmann-La Roche Ltd, Takeda Pharmaceuticals, Pfizer Inc, AbbVie Inc, Immunomedics, ImmunoGen Inc, Lonza, Creative Biolabs

Antibody Drug Conjugate Drug Market Segment Analysis:
By Product
Adcertis
Kadcyla
Technology
ImmunoGen technology
Seattle Genetics technology
Immunomedics technology
End User
Hospitals
Specialized Cancer Centers
Academic Research Institutes
Biotechnology Companies
Biopharmaceutical Companies
Others

Geographic Coverage for Antibody Drug Conjugate Drug Market:
The market research report on global Antibody Drug Conjugate Drug market offers complete analysis across various regions across the world. The Antibody Drug Conjugate Drug market is distributed into various regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The global leading market share as per the region is evaluated after considering Antibody Drug Conjugate Drug market revenue, sales, shares, recent developments, innovations and growth rates. This section of regional analysis provides widespread evaluation of the industry from various countries and regions.

North America Antibody Drug Conjugate Drug Market Value and Forecast
  • US
  • Canada
Europe Antibody Drug Conjugate Drug Market Value and Forecast
  • UK
  • Germany
  • France
  •  Rest of Europe
Asia Pacific Antibody Drug Conjugate Drug Market Value and Forecast
  • China
  • Japan
  • India
  • Rest of Asia Pacific
Latin America Antibody Drug Conjugate Drug Market Value and Forecast
  • Mexico
  • Brazil
  • Rest of Latin America
Middle East and Africa Antibody Drug Conjugate Drug Market Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa


Key highlights of the Antibody Drug Conjugate Drug market report:
  • The report provides key trends of the global Antibody Drug Conjugate Drug market
  • The report also covers consumer preferences and current industry growth
  • Key products or solutions offered by the main players in the Antibody Drug Conjugate Drug industry
  • The report covers all the recent developments of the Antibody Drug Conjugate Drug market and helps to provide current industry updates
  • The report covers a detailed look over the global Antibody Drug Conjugate Drug Industry and provides with significant actionable insights
  • The Antibody Drug Conjugate Drug market estimation from 2020-2028 and historical data for 2018 and 2019
  • The market study also provides data on changing market dynamics, market intelligence, current and future market trends
  • The report also analyses the microeconomic and macroeconomic factors that are affecting the global Antibody Drug Conjugate Drug market
  • In-depth analysis of the market’s competitive landscape and detailed information about the vendors
  • The report also offers key market drivers, restrains, trends and opportunities with present and future impact on the market
  • Detailed information about the major players or manufacturers of the global Antibody Drug Conjugate Drug market
  • Comprehensive analysis of the Antibody Drug Conjugate Drug market segments based on its types, applications and end-use industry
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Antibody Drug Conjugate Drug market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Antibody Drug Conjugate Drug market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

      2.  Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Antibody Drug Conjugate Drug market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Antibody Drug Conjugate Drug market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

      3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Antibody Drug Conjugate Drug market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Genentech USA, Inc
  • Seattle Genetics
  • F. Hoffmann-La Roche Ltd
  • Takeda Pharmaceuticals
  • Pfizer Inc
  • AbbVie Inc
  • Immunomedics
  • ImmunoGen Inc
  • Lonza
  • Creative Biolabs
  • Adcertis
  • Kadcyla
  • Hospitals
  • Specialized Cancer Centers
  • Academic Research Institutes
  • Biotechnology Companies
  • Biopharmaceutical Companies
  • Others

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Antibody Drug Conjugate Drug Market Snapshot
          2.1.1. Global Antibody Drug Conjugate Drug Market By Product,2019
               2.1.1.1.Adcertis
               2.1.1.2.Kadcyla
          2.1.2. Global Antibody Drug Conjugate Drug Market By End User,2019
               2.1.2.1.Hospitals
               2.1.2.2.Specialized Cancer Centers
               2.1.2.3.Academic Research Institutes
               2.1.2.4.Biotechnology Companies
               2.1.2.5.Biopharmaceutical Companies
               2.1.2.6.Others
          2.1.3. Global Antibody Drug Conjugate Drug Market By End-use,2019
          2.1.4. Global Antibody Drug Conjugate Drug Market By Geography,2019

3. Global Antibody Drug Conjugate Drug Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Antibody Drug Conjugate Drug Market Size (US$), By Product, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Product, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Product, 2020
     4.2. Global Antibody Drug Conjugate Drug Market Size (US$), By Product, 2018 – 2028

5. Global Antibody Drug Conjugate Drug Market Size (US$), By End User, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By End User, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By End User, 2020
     5.2. Global Antibody Drug Conjugate Drug Market Size (US$), By End User, 2018 – 2028

6. Global Antibody Drug Conjugate Drug Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Antibody Drug Conjugate Drug Market Size (US$), By End-use, 2018 – 2028

7. Global Antibody Drug Conjugate Drug Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Antibody Drug Conjugate Drug Market Analysis, 2018 – 2028 
          7.2.1. North America Antibody Drug Conjugate Drug Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Antibody Drug Conjugate Drug Market Size (US$), By Product, 2018 – 2028
          7.2.3. North America Antibody Drug Conjugate Drug Market Size (US$), By End User, 2018 – 2028
          7.2.4. North America Antibody Drug Conjugate Drug Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Antibody Drug Conjugate Drug Market Analysis, 2018 – 2028 
          7.3.1.  Europe Antibody Drug Conjugate Drug Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Antibody Drug Conjugate Drug Market Size (US$), By Product, 2018 – 2028
          7.3.3. Europe Antibody Drug Conjugate Drug Market Size (US$), By End User, 2018 – 2028
          7.3.4. Europe Antibody Drug Conjugate Drug Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Antibody Drug Conjugate Drug Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Antibody Drug Conjugate Drug Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Antibody Drug Conjugate Drug Market Size (US$), By Product, 2018 – 2028
          7.4.3. Asia Pacific Antibody Drug Conjugate Drug Market Size (US$), By End User, 2018 – 2028
          7.4.4. Asia Pacific Antibody Drug Conjugate Drug Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Antibody Drug Conjugate Drug Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Antibody Drug Conjugate Drug Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Antibody Drug Conjugate Drug Market Size (US$), By Product, 2018 – 2028
          7.5.3. Latin America Antibody Drug Conjugate Drug Market Size (US$), By End User, 2018 – 2028
          7.5.4. Latin America Antibody Drug Conjugate Drug Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Antibody Drug Conjugate Drug Market Analysis, 2018 – 2028 
          7.6.1.  MEA Antibody Drug Conjugate Drug Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Antibody Drug Conjugate Drug Market Size (US$), By Product, 2018 – 2028
          7.6.3. MEA Antibody Drug Conjugate Drug Market Size (US$), By End User, 2018 – 2028
          7.6.4. MEA Antibody Drug Conjugate Drug Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Antibody Drug Conjugate Drug Providers
        8.4.1 Genentech USA, Inc
                8.4.1.1 Business Description
                8.4.1.2 Genentech USA, Inc Geographic Operations
                8.4.1.3 Genentech USA, Inc Financial Information
                8.4.1.4 Genentech USA, Inc Product Positions/Portfolio
                8.4.1.5 Genentech USA, Inc Key Developments
        8.4.2 Seattle Genetics
                8.4.2.1 Business Description
                8.4.2.2 Seattle Genetics Geographic Operations
                8.4.2.3 Seattle Genetics Financial Information
                8.4.2.4 Seattle Genetics Product Positions/Portfolio
                8.4.2.5 Seattle Genetics Key Developments
        8.4.3 F. Hoffmann-La Roche Ltd
                8.4.3.1 Business Description
                8.4.3.2 F. Hoffmann-La Roche Ltd Geographic Operations
                8.4.3.3 F. Hoffmann-La Roche Ltd Financial Information
                8.4.3.4 F. Hoffmann-La Roche Ltd Product Positions/Portfolio
                8.4.3.5 F. Hoffmann-La Roche Ltd Key Developments
        8.4.4 Takeda Pharmaceuticals
                8.4.4.1 Business Description
                8.4.4.2 Takeda Pharmaceuticals Geographic Operations
                8.4.4.3 Takeda Pharmaceuticals Financial Information
                8.4.4.4 Takeda Pharmaceuticals Product Positions/Portfolio
                8.4.4.5 Takeda Pharmaceuticals Key Developments
        8.4.5 Pfizer Inc
                8.4.5.1 Business Description
                8.4.5.2 Pfizer Inc Geographic Operations
                8.4.5.3 Pfizer Inc Financial Information
                8.4.5.4 Pfizer Inc Product Positions/Portfolio
                8.4.5.5 Pfizer Inc Key Developments
        8.4.6 AbbVie Inc
                8.4.6.1 Business Description
                8.4.6.2 AbbVie Inc Geographic Operations
                8.4.6.3 AbbVie Inc Financial Information
                8.4.6.4 AbbVie Inc Product Positions/Portfolio
                8.4.6.5 AbbVie Inc Key Developments
        8.4.7 Immunomedics
                8.4.7.1 Business Description
                8.4.7.2 Immunomedics Geographic Operations
                8.4.7.3 Immunomedics Financial Information
                8.4.7.4 Immunomedics Product Positions/Portfolio
                8.4.7.5 Immunomedics Key Developments
        8.4.8 ImmunoGen Inc
                8.4.8.1 Business Description
                8.4.8.2 ImmunoGen Inc Geographic Operations
                8.4.8.3 ImmunoGen Inc Financial Information
                8.4.8.4 ImmunoGen Inc Product Positions/Portfolio
                8.4.8.5 ImmunoGen Inc Key Developments
        8.4.9 Lonza
                8.4.9.1 Business Description
                8.4.9.2 Lonza Geographic Operations
                8.4.9.3 Lonza Financial Information
                8.4.9.4 Lonza Product Positions/Portfolio
                8.4.9.5 Lonza Key Developments
        8.4.10 Creative Biolabs
                8.4.10.1 Business Description
                8.4.10.2 Creative Biolabs Geographic Operations
                8.4.10.3 Creative Biolabs Financial Information
                8.4.10.4 Creative Biolabs Product Positions/Portfolio
                8.4.10.5 Creative Biolabs Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Antibody Drug Conjugate Drug Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Antibody Drug Conjugate Drug Market Revenue, By Product, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Antibody Drug Conjugate Drug Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Antibody Drug Conjugate Drug Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Antibody Drug Conjugate Drug Market Revenue, By Product, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Antibody Drug Conjugate Drug Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Antibody Drug Conjugate Drug Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Antibody Drug Conjugate Drug Market Revenue, By Product, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Antibody Drug Conjugate Drug Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Antibody Drug Conjugate Drug Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Antibody Drug Conjugate Drug Market Revenue, By Product, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Antibody Drug Conjugate Drug Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Antibody Drug Conjugate Drug Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Antibody Drug Conjugate Drug Market Revenue, By Product, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Antibody Drug Conjugate Drug Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Antibody Drug Conjugate Drug Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Antibody Drug Conjugate Drug: Market Segmentation 
FIG. 2 Global Antibody Drug Conjugate Drug Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Antibody Drug Conjugate Drug Market, By Product, 2019 (US$ Mn) 
FIG. 5 Global Antibody Drug Conjugate Drug Market, By End User, 2019 (US$ Mn) 
FIG. 6 Global Antibody Drug Conjugate Drug Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Antibody Drug Conjugate Drug Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Antibody Drug Conjugate Drug Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Antibody Drug Conjugate Drug Providers, 2019
FIG. 11 Global Antibody Drug Conjugate Drug Market Revenue Contribution, By Product, 2019 & 2028 (Value %) 
FIG. 12 Global Antibody Drug Conjugate Drug Market Revenue Contribution, By End User, 2019 & 2028 (Value %) 
FIG. 13 Global Antibody Drug Conjugate Drug Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Antibody Drug Conjugate Drug Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Antibody Drug Conjugate Drug Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Antibody Drug Conjugate Drug Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Antibody Drug Conjugate Drug Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Antibody Drug Conjugate Drug Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Antibody Drug Conjugate Drug market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Antibody Drug Conjugate Drug Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Antibody Drug Conjugate Drug Market Value, By Segment1, 2018 – 2028
TABLE  North America Antibody Drug Conjugate Drug Market Value, By Segment2, 2018 – 2028
TABLE  North America Antibody Drug Conjugate Drug Market Value, By Country, 2018 – 2028
TABLE  Europe Antibody Drug Conjugate Drug Market Value, By Segment1, 2018 – 2028
TABLE  Europe Antibody Drug Conjugate Drug Market Value, By Segment2, 2018 – 2028
TABLE  Europe Antibody Drug Conjugate Drug Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Antibody Drug Conjugate Drug Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Antibody Drug Conjugate Drug Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Antibody Drug Conjugate Drug Market Value, By Country, 2018 – 2028
TABLE  Latin America Antibody Drug Conjugate Drug Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Antibody Drug Conjugate Drug Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Antibody Drug Conjugate Drug Market Value, By Country, 2018 – 2028
TABLE  MEA Antibody Drug Conjugate Drug Market Value, By Segment1, 2018 – 2028
TABLE  MEA Antibody Drug Conjugate Drug Market Value, By Segment2, 2018 – 2028
TABLE  MEA Antibody Drug Conjugate Drug Market Value, By Country, 2018 – 2028
TABLE  Genentech USA, Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Seattle Genetics: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  F. Hoffmann-La Roche Ltd: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Takeda Pharmaceuticals: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Pfizer Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  AbbVie Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Immunomedics: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  ImmunoGen Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Lonza: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Creative Biolabs: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Antibody Drug Conjugate Drug Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Antibody Drug Conjugate Drug Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Antibody Drug Conjugate Drug Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Antibody Drug Conjugate Drug Market, By Geography, 2019 (US$ Mn)
FIG.  Global Antibody Drug Conjugate Drug Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Antibody Drug Conjugate Drug Providers, 2016
FIG.  Global Antibody Drug Conjugate Drug Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Kadcyla Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Antibody Drug Conjugate Drug Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Specialized Cancer Centers Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Academic Research Institutes Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Biotechnology Companies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Biopharmaceutical Companies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Antibody Drug Conjugate Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Antibody Drug Conjugate Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Antibody Drug Conjugate Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Antibody Drug Conjugate Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Antibody Drug Conjugate Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Antibody Drug Conjugate Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Antibody Drug Conjugate Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Antibody Drug Conjugate Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Antibody Drug Conjugate Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Antibody Drug Conjugate Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Antibody Drug Conjugate Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Antibody Drug Conjugate Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Antibody Drug Conjugate Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Antibody Drug Conjugate Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Antibody Drug Conjugate Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Antibody Drug Conjugate Drug Market Value, 2018 – 2028, (US$ Mn)